Filter
2502
Filtered Results: 2502
Text search:
Pharmaceuticals
Featured
Recommendations
226
New Publications
632
Language
Document type
No document type
1189
Studies & Reports
507
Guidelines
403
Manuals
118
Strategic & Response Plan
113
Fact sheets
67
Training Material
33
Resource Platforms
21
Situation Updates
19
Infographics
15
Brochures
11
Online Courses
6
Countries / Regions
Global
107
Kenya
97
Ethiopia
89
India
88
South Africa
60
Western and Central Europe
51
Nigeria
50
Sierra Leone
43
Uganda
43
Liberia
42
Namibia
39
Rwanda
35
Nepal
34
Ghana
34
Tanzania
31
Malawi
29
Africa
29
Latin America and the Carribbean
29
Bangladesh
29
Zambia
29
Ukraine
27
Zimbabwe
22
Philippines
22
Germany
21
Eastern Europe
21
Indonesia
19
Syria
18
Lesotho
17
Cambodia
17
South–East Asia Region
17
Congo, Democratic Republic of
16
Myanmar / Burma
16
West and Central Africa
13
Botswana
13
Eswatini/ Swaziland
13
Russia
12
Eastern Europe and Central Asia
11
Guinea
9
Asia
9
Venezuela
9
East and Southern Africa
9
South Sudan
9
Cameroon
8
Senegal
8
Brazil
8
Benin
7
Burkina Faso
7
Mozambique
7
Haiti
7
Thailand
6
Chile
6
Middle East and North Africa
6
Western Pacific Region
6
Vietnam
6
Albania
5
Papua New Guinea
5
Pakistan
5
China
4
Laos
4
Sudan
4
Madagascar
4
North Macedonia
3
Tajikistan
3
Fiji
3
Afghanistan
3
Peru
3
USA
3
Jordan
3
North America
3
United Kingdom
3
Lebanon
3
Egypt
3
Mali
3
Angola
3
El Salvador
2
Serbia
2
Kyrgyzstan
2
Lithuania
2
Paraguay
2
Jamaica
2
Spain
2
Bolivia
2
Argentina
2
Moldova
2
Yemen
2
Georgia
2
Central African Republic
2
Iraq
2
Colombia
1
Timor Leste/ East Timor
1
Australia
1
Kazakhstan
1
Iran
1
Canada
1
Niger
1
Uzbekistan
1
Malaysia
1
Mongolia
1
Bulgaria
1
Armenia
1
Dominican Republic
1
Guinea-Bissau
1
Ireland
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Portugal
1
Southern Africa
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Sri Lanka
1
Romania
1
Palestine
1
Honduras
1
Chad
1
Libya
1
Bhutan
1
Somalia
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1000
Clinical Guidelines
147
Public Health
116
Key Resources
116
Women & Child Health
57
Pharmacy & Technologies
43
Capacity Building
16
Annual Report MEDBOX
2
Toolboxes
Pharmacy
247
COVID-19
240
AMR
230
Mental Health
132
HIV
119
TB
111
NTDs
90
Rapid Response
67
Planetary Health
63
NCDs
60
Caregiver
48
Ebola & Marburg
46
Health Financing Toolbox
46
Global Health Education
43
Conflict
40
Malaria
27
Refugee
25
Disability
18
Specific Hazards
14
Natural Hazards
13
Polio
12
Social Ethics
5
Cholera
4
Zika
4
South Sudan
1
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
Transactions of The Royal Society of Tropical Medicine and Hygiene, Volume 115, Issue 2, February 2021, Pages 136–144, https://doi.org/10.1093/trstmh/traa167.
Neglected tropical diseases (NTDs) are targeted for global control or elimination. Recognising that the populations most in need of medici...
The Pandemic Influenza Preparedness (PIP) Framework is a World Health Assembly resolution adopted unanimously by all Member States in 2011. It brings together Member States, industry, other stakeholders and WHO to implement a global approach to pandemic influenza preparedness and response. The Frame...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato...
Neglected tropical diseases (NTDs) is an umbrella term for a diverse group of debilitating infections that represent the most common afflictions for 2.7 billion people living on less than US$2 per day. Major efforts have recently re-focused attention on NTDs, including structured advocacy by the Bil...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj...
Accessed: 02.05.2020
These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Development (USAID) Medicines, Technologies, and Pharmaceu...
The Pandemic Influenza Preparedness (PIP) Framework is a World Health Assembly resolution adopted unanimously by all Member States in 2011. It brings together Member States, industry, other stakeholders and WHO to implement a global approach to pandemic influenza preparedness and response. The Frame...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec...
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac...
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Venezuela’s government announced on 24 March that COVID-19 infections had reached 91... “The government says wear masks, wash your hands often, and stay inside,” Gomez said. “But we don’t have water, we often don’t have electricity, and there are no masks.”...
[President] Maduro den...
August 2020.
Essential diagnostic products areconsidered an integral part of UHC, they are an indispensable element for delivery ofservices andare also a requirement for qualitycare. Despite this realization, a review of the UHC pilot in September 2019 es...
The Ethiopian Hospital Services Transformation Guidelines (EHSTG) build on and expand the Ethiopian Hospital Reform Implementation Guidelines (EHRIG) and are consistent with the Health Sector Transformation Plan (HSTP). The EHSTG, which is consistent with the national focu...
Training Manual
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
